Health
Freiburg researchers receive ERC funding to develop and test immunostimulatory drug candidates – News-Medical.net
With the Proof of Concept funding line, the ERC grants recipients of ERC frontier research funds (Starting, Consolidator, Advanced or Synergy grants) with 150.000…
With the Proof of Concept funding line, the ERC grants recipients of ERC frontier research funds (Starting, Consolidator, Advanced or Synergy grants) with 150.000 Euro to develop promising ideas with commercial or societal potential to the proof of concept stage. With this funding, Olaf Groß and his team in the Metabolism and Inflammation Group at the Institute of Neuropathology of the Medical Center – University of Freiburg will test whether a new class of immune activating drugs they discovered…
-
General12 hours agoFerries and celebrities as pollies dash to win the west
-
Noosa News17 hours agoCSIRO, winemakers pair to breed mildew, climate-resistant grapevines
-
Noosa News14 hours agoChild killer Rick Thorburn who murdered Tiahleigh Palmer found dead in jail cell
-
Noosa News21 hours agoSpinach salads back on supermarket shelves amid E. coli probe